Cases 1 - 4 of 4
Hoffmann-La Roche, Inc. et al v. Fresenius Kabi USA, LLC et al
as 1:2020cv00394
Defendant:
Fresenius Kabi Oncology Limited, Fresenius SE & Co. KGaA and Fresenius Kabi USA, LLC
Plaintiff:
Hoffmann-La Roche, Inc., Chugai Pharmaceutical Co. Ltd. and Genentech, Inc.
Cause Of Action: 35 U.S.C. § 271
MERCK SHARP & DOHME B.V. et al v. FRESENIUS KABI USA, LLC et al
as 2:2020cv02892
Defendant:
FRESENIUS KABI ONCOLOGY LIMITED and FRESENIUS KABI USA, LLC
Plaintiff:
ORGANON USA INC. and MERCK SHARP & DOHME B.V.
Cause Of Action: 35 U.S.C. § 271
Pharmacyclics LLC et al v. Sandoz Inc. et al
as 1:2018cv00192
Defendant:
Fresenius Kabi Oncology Limited, Fresenius Kabi USA, Inc., Fresenius Kabi USA, LLC and others
Plaintiff:
Pharmacyclics LLC and Janssen Biotech Inc.
Counter Claimant:
Cipla USA Inc., Lek Pharmaceuticals d.d., Cadila Healthcare Limited and others
Cause Of Action: 35 U.S.C. § 271
Onyx Therapeutics, Inc. v. Fresenius Kabi USA, LLC et al
as 1:2016cv01012
Plaintiff:
Onyx Therapeutics, Inc.
Defendant:
Fresenius Kabi USA, LLC , Fresenius Kabi USA, Inc. , Fresenius Kabi Pharmaceuticals Holding, Inc. and others
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
